SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Viridien (CGGYY) 当前追踪市盈率 (P/E) 为 22.9, 前瞻市盈率为 2.6. 追踪盈利收益率为 4.36%, 前瞻盈利收益率 39.22%.
本页证实的标准:
- VALUE (75/100, 通过) — 市盈率低于市场平均水平 (22.9); 盈利收益率超过债券收益率 (4.36%).
- 前瞻市盈率 2.6 (低于追踪值 22.9) — 分析师预计盈利将增长，这将改善估值。
- 追踪盈利收益率 4.36% — 与债券收益率（约4.3%）大致持平，风险回报适中。 前瞻收益率改善至 39.22% 随着盈利恢复。
SharesGrow 综合评分： 61/100 其中 3/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
75/100
Price-to-Earnings & upside
Proven by this page
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — CGGYY
估值倍数
P/E (TTM)22.9
前瞻 P/E2.6
PEG 比率N/A
前瞻 PEG0.00
P/B 比率0.00
P/S 比率0.28
EV/EBITDA0.0
每股数据
EPS (TTM)$1.80
前瞻 EPS（预估）$16.20
每股账面价值$0.00
每股营收$150.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率4.36%
Forward Earnings Yield39.22%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2014 |
$-4,943.00 |
$3.1B |
$-1.15B |
-37.3% |
| 2015 |
$-6,207.00 |
$2.1B |
$-1.45B |
-69% |
| 2016 |
$-1,326.00 |
$1.2B |
$-573.4M |
-47.9% |
| 2017 |
$-1,118.00 |
$1.32B |
$-514.9M |
-39% |
| 2018 |
$-16.00 |
$1.19B |
$-101.6M |
-8.5% |
| 2019 |
$18.00 |
$1.36B |
$126.3M |
9.3% |
| 2020 |
$-53.00 |
$886.7M |
$-375.7M |
-42.4% |
| 2021 |
$-26.00 |
$1.06B |
$-181.7M |
-17.1% |
| 2022 |
$9.28 |
$927.4M |
$66.3M |
7.1% |
| 2023 |
$1.80 |
$1.08B |
$12.9M |
1.2% |
